Menveo (Novartis Vaccines and Diagnostics s.r.l.)
Welcome to the PulseAid listing for the Menveo drug offered from Novartis Vaccines and Diagnostics s.r.l.. This pharmaceutical is classified as a VACCINE. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same VACCINE drug type category.
LABELER NAME / MANUFACTURER: | Novartis Vaccines and Diagnostics s.r.l. |
NON-PROPRIETARY NAME: | Meningococcal (Groups A, C, Y and W-135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine |
SUBSTANCE NAME: | |
TYPE: | VACCINE |
PHARMA CLASS: | |
ROUTE: | |
DOSAGE FORM: | KIT |
MARKETING CATEGORY NAME: | BLA |
START MARKETING DATE: | 2010-02-19 |
END MARKETING DATE: | 2018-04-30 |
Menveo VACCINE Details:
Item Description | Menveo from Novartis Vaccines and Diagnostics s.r.l. |
LABELER NAME: | Novartis Vaccines and Diagnostics s.r.l. |
DEA SCHEDULE: | |
ACTIVE STRENGTH: | () |
START MARKETING DATE: | 2010-02-19 |
END MARKETING DATE: | 2018-04-30 |
PRODUCT ID: | 46028-208_2f98ff12-1e2c-4eda-b8cb-161a11da65c6 |
PRODUCT NDC: | 46028-208 |
APPLICATION NUMBER: | BLA125300 |